The Cytotoxic, Apoptotic and Oxidative Effects of Carbonic Anhydrase Ix Inhibitor on Colorectal Cancer Cells

dc.contributor.author Tuluce, Yasin
dc.contributor.author Ahmed, Bewar Ali
dc.contributor.author Koyuncu, Ismail
dc.contributor.author Durgun, Mustafa
dc.date.accessioned 2025-05-10T17:04:37Z
dc.date.available 2025-05-10T17:04:37Z
dc.date.issued 2018
dc.description Koyuncu, Ismail/0000-0002-9469-4757; Durgun, Mustafa/0000-0003-3012-7582; Tuluce, Yasin/0000-0002-7312-5934 en_US
dc.description.abstract Colorectal cancer (CRC) is the third most common tumor, malignant and has developed one of the main reasons of cancer mortality. According to studies conducted recently; carbonic anhydrase 9 (CAIX) is an especially attractive target for cancer therapy, in part since it is limited way expressed in normal tissues on the other hand in a wide variety of solid neoplasia are overexpressed. The aim of this study was to appreciate the effects of CAIX inhibitor, namely novel synthesized sulfonamide derivative (H-4i) with high affinity for CAIX, in CAIX-positive human colorectal cancer cell (HT-29) and CAIX-negative human normal embryonic kidney cell line (HEK-293). For this reason, we planned to investigate apoptotic, cytotoxic and oxidative stress activity of H-4i on HT-29 and HEK-293 cell lines. Cell viability determined by WST-1 assay afterwards IC50 values, apoptosis and cell cycle induction measured by flow cytometric analysis, intracellular free radical induction performed by reactive oxygen species (ROS) analyses. The IC50 value of the sulfonamide derivative compound was found to be very low, especially in HT-29 cells, when compared to human normal cells. This research found that H-4i significantly increased cytotoxicity and ROS production, caused significant signs of apoptosis level. High level of ROS and apoptosis lead to arrest the cell cycle and reduce cell survival. The most obvious finding to emerge from the analysis that novel synthesized sulfonamide derivative H-4i is effective on HT-29 more than HEK-293. Therefore, novel derivative H-4i might be used as an anti-cancer potential compound on CRC. en_US
dc.identifier.doi 10.1007/s10863-018-9749-9
dc.identifier.issn 0145-479X
dc.identifier.issn 1573-6881
dc.identifier.scopus 2-s2.0-85043391008
dc.identifier.uri https://doi.org/10.1007/s10863-018-9749-9
dc.identifier.uri https://hdl.handle.net/20.500.14720/6072
dc.language.iso en en_US
dc.publisher Springer/plenum Publishers en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Carbonic Anhydrase-9 Inhibitor en_US
dc.subject Colorectal Cancer en_US
dc.subject Apoptosis en_US
dc.subject Cytotoxicity en_US
dc.subject And Oxidative Stress en_US
dc.title The Cytotoxic, Apoptotic and Oxidative Effects of Carbonic Anhydrase Ix Inhibitor on Colorectal Cancer Cells en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Koyuncu, Ismail/0000-0002-9469-4757
gdc.author.id Durgun, Mustafa/0000-0003-3012-7582
gdc.author.id Tuluce, Yasin/0000-0002-7312-5934
gdc.author.scopusid 10143414500
gdc.author.scopusid 57201085666
gdc.author.scopusid 57203094952
gdc.author.scopusid 55078111000
gdc.author.wosid Koyuncu, Ismail/Abf-8907-2020
gdc.author.wosid Durgun, Mustafa/Aag-4570-2019
gdc.author.wosid Tuluce, Yasin/S-6812-2016
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
gdc.description.departmenttemp [Tuluce, Yasin; Ahmed, Bewar Ali] Van Yuzuncu Yil Univ, Dept Med Biol, Fac Med, Van, Turkey; [Koyuncu, Ismail] Harran Univ, Dept Biochem, Fac Med, Sanliurfa, Turkey; [Durgun, Mustafa] Harran Univ, Dept Chem, Fac Sci & Art, Sanliurfa, Turkey en_US
gdc.description.endpage 116 en_US
gdc.description.issue 2 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q3
gdc.description.startpage 107 en_US
gdc.description.volume 50 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q2
gdc.identifier.pmid 29520697
gdc.identifier.wos WOS:000429796900003
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed

Files